Astra Biotech has produced a portfolio of assays in areas such as allergies, genetically associated disorders, hormonal dysfunctions and others.
Key targets so far are for osteoporosis, a condition that affects more than 75 million people worldwide and thrombosis, a major fatal disease in developed countries.
Other diagnostic kits include one for the determination of an individual's susceptibility or resistance to oral anticoagulants, as well as niche diseases.
Other products include a wide range of Elisa assays that are said to offer value for money to small- or medium-sized laboratories.
A particular focus of Astra Biotech's Elisa assays is the fertility range, along with pre- and neonatal test kits.
The company will soon be releasing its Educator Series - a range of assays specifically for the teaching of analytical procedures without the high costs normally associated with such techniques.
An array technology for improved hybridisation will also become available shortly.
This 'microarray-on-a-chip' will determine predisposition to a variety of conditions.
All assays are IVD compliant and are therefore suitable for direct diagnostic purposes and not just for research.
